Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies Market Cap : 1.305B for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.323B |
| November 13, 2026 | 1.336B |
| November 12, 2026 | 1.372B |
| November 11, 2026 | 1.395B |
| November 10, 2026 | 1.393B |
| November 09, 2026 | 1.422B |
| November 06, 2026 | 1.409B |
| November 05, 2026 | 1.330B |
| November 04, 2026 | 1.418B |
| November 03, 2026 | 1.330B |
| November 02, 2026 | 1.301B |
| October 30, 2026 | 1.343B |
| October 29, 2026 | 1.373B |
| October 28, 2026 | 1.376B |
| October 27, 2026 | 1.383B |
| October 26, 2026 | 1.304B |
| October 23, 2026 | 1.288B |
| October 22, 2026 | 1.303B |
| October 21, 2026 | 1.340B |
| October 20, 2026 | 1.337B |
| October 19, 2026 | 1.282B |
| October 16, 2026 | 1.178B |
| October 15, 2026 | 1.213B |
| October 14, 2026 | 1.142B |
| October 13, 2026 | 1.165B |
| Date | Value |
|---|---|
| October 12, 2026 | 1.347B |
| October 09, 2026 | 1.461B |
| October 08, 2026 | 1.441B |
| October 07, 2026 | 1.441B |
| October 06, 2026 | 1.428B |
| October 05, 2026 | 1.461B |
| October 02, 2026 | 1.506B |
| October 01, 2026 | 1.542B |
| September 30, 2026 | 1.584B |
| September 29, 2026 | 1.623B |
| September 28, 2026 | 1.623B |
| September 25, 2026 | 1.519B |
| September 24, 2026 | 1.558B |
| September 23, 2026 | 1.597B |
| September 22, 2026 | 1.679B |
| September 21, 2026 | 1.640B |
| September 18, 2026 | 1.633B |
| September 17, 2026 | 1.679B |
| September 16, 2026 | 1.649B |
| September 15, 2026 | 1.646B |
| September 14, 2026 | 1.630B |
| September 11, 2026 | 1.633B |
| September 10, 2026 | 1.679B |
| September 09, 2026 | 1.737B |
| September 08, 2026 | 1.783B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Imunon, Inc. | 3.830M |
| Altimmune, Inc. | 298.62M |
| Agenus, Inc. | 281.42M |
| Amgen, Inc. | 247.68B |
| Anika Therapeutics, Inc. | 172.65M |
Market Cap Related Metrics
| PS Ratio | 260.46 |
| PEG Ratio | -0.3978 |
| Price to Book Value | 3.656 |
| Price | 4.005 |
| Earnings Yield | -10.89% |
| PEGY Ratio | -0.3978 |